
Summit Therapeutics Announces Inducement Equity Grants Under Nasdaq Rule 5635(c)(4)
Summit Therapeutics Issues Inducement Awards Pursuant to Nasdaq Listing a biopharmaceutical company focused on developing innovative therapies for serious diseases, today announced the issuance of inducement equity awards in the form of stock options to nine newly hired employees. The…












